COVINA, CA -- (MARKET WIRE) -- September 11, 2006 -- Healtheuniverse, Inc. (PINKSHEETS: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, announced today that it has entered into an agreement with The California Institute of Cosmetic and Reconstructive Surgery (C.I.C.R.S.) for clinical research, marketing and distribution rights for fat based stem cell technology and products in the United States. The agreement provides for CICRS to conduct clinical trials in the United States for fat based stem cell applications in the areas of cosmetic, plastic, and reconstructive surgery. CICRS grants Healtheuniverse patent, technology, IP, and licensing rights to market and sell products developed by these clinical trials, if they are approved for marketing.
